{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T03:29:52Z","timestamp":1773890992093,"version":"3.50.1"},"reference-count":239,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100024591","name":"National Institute of Pharmaceutical Education and Research, Kolkata","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024591","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001501","name":"University Grants Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001780","name":"RMIT University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008812","name":"Defence Science and Technology Group","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008812","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.rmed.2025.108519","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T07:41:36Z","timestamp":1763538096000},"page":"108519","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Emerging molecular targets and natural therapeutics for idiopathic pulmonary fibrosis: Insights into mechanisms, risks, and COVID-19 links"],"prefix":"10.1016","volume":"250","author":[{"given":"Rashmi","family":"Singh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-0698-8440","authenticated-orcid":false,"given":"Aditya Kumar","family":"Pradhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7671-3167","authenticated-orcid":false,"given":"Dipanjan","family":"Roy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mansi","family":"Arya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rudra","family":"Chakravarti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0556-7634","authenticated-orcid":false,"given":"Debrupa","family":"Dutta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anirban","family":"Kundu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Swapnesh","family":"Bhaduri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-0046-9690","authenticated-orcid":false,"given":"Prabhjot","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1663-6858","authenticated-orcid":false,"given":"Kazi Tawsif","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3697-8209","authenticated-orcid":false,"given":"Bireswar","family":"Bhattacharya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.rmed.2025.108519_bib1","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.amjms.2019.02.013","article-title":"Idiopathic pulmonary fibrosis: epidemiology, diagnosis and outcomes","volume":"357","author":"Wakwaya","year":"2019","journal-title":"Am. J. Med. Sci."},{"issue":"1","key":"10.1016\/j.rmed.2025.108519_bib2","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/s12931-021-01791-z","article-title":"Global incidence and prevalence of idiopathic pulmonary fibrosis","volume":"22","author":"Maher","year":"2021","journal-title":"Respir. Res."},{"issue":"1","key":"10.1016\/j.rmed.2025.108519_bib3","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1755-1536-5-11","article-title":"Molecular and cellular mechanisms of pulmonary fibrosis","volume":"5","author":"Todd","year":"2012","journal-title":"Fibrogenesis Tissue Repair"},{"issue":"1","key":"10.1016\/j.rmed.2025.108519_bib4","doi-asserted-by":"crossref","first-page":"201","DOI":"10.21776\/ub.mrj.2022.004.01.2","article-title":"A confirmed case of idiopathic pulmonary fibrosis-probable usual interstitial pneumonia pattern through Lung biopsy","volume":"4","author":"Kristiani","year":"2022","journal-title":"Malang Respir J."},{"key":"10.1016\/j.rmed.2025.108519_bib5","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s13665-018-0210-7","article-title":"Risk factors for the development of idiopathic pulmonary fibrosis: a review","volume":"7","author":"Zaman","year":"2018","journal-title":"Curr. Pulmonol. Rep."},{"issue":"2","key":"10.1016\/j.rmed.2025.108519_bib6","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/mi.2008.85","article-title":"Pulmonary fibrosis: pathogenesis, etiology and regulation","volume":"2","author":"Wilson","year":"2009","journal-title":"Mucosal Immunol."},{"issue":"2","key":"10.1016\/j.rmed.2025.108519_bib7","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0002-9343(80)90364-2","article-title":"Cytotoxic drug-induced pulmonary disease: update 1980","volume":"68","author":"Weiss","year":"1980","journal-title":"Am. J. Med."},{"issue":"2","key":"10.1016\/j.rmed.2025.108519_bib8","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1183\/09031936.93.03020202","article-title":"Metal toxicity and the respiratory tract","volume":"3","author":"Nemery","year":"1990","journal-title":"Eur. Respir. J."},{"issue":"1","key":"10.1016\/j.rmed.2025.108519_bib9","first-page":"39","article-title":"Pulmonary immunotoxicology of select metals: aluminum, arsenic, cadmium, chromium, copper, manganese, nickel, vanadium, and zinc","volume":"1","author":"Cohen","year":"2004","journal-title":"J. Immunot."},{"issue":"2","key":"10.1016\/j.rmed.2025.108519_bib10","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1471-1842.2009.00848.x","article-title":"A typology of reviews: an analysis of 14 review types and associated methodologies","volume":"26","author":"Grant","year":"2009","journal-title":"Health Inf. Libr. J."},{"key":"10.1016\/j.rmed.2025.108519_bib11","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.jbusres.2019.07.039","article-title":"Literature review as a research methodology: an overview and guidelines","volume":"104","author":"Snyder","year":"2019","journal-title":"J. Bus. Res."},{"issue":"1","key":"10.1016\/j.rmed.2025.108519_bib12","doi-asserted-by":"crossref","first-page":"L68","DOI":"10.1152\/ajplung.00188.2016","article-title":"SIRT3 blocks myofibroblast differentiation and pulmonary fibrosis by preventing mitochondrial DNA damage","volume":"312","author":"Bindu","year":"2017","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.rmed.2025.108519_bib13","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1007\/s00018-020-03693-7","article-title":"Emerging cellular and molecular determinants of idiopathic pulmonary fibrosis","volume":"78","author":"Phan","year":"2021","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.rmed.2025.108519_bib14","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1146\/annurev.med.55.091902.103810","article-title":"Mechanisms of pulmonary fibrosis","volume":"55","author":"Thannickal","year":"2004","journal-title":"Annu. Rev. Med."},{"issue":"124","key":"10.1016\/j.rmed.2025.108519_bib15","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1183\/09059180.00001012","article-title":"Unravelling the progressive pathophysiology of idiopathic pulmonary fibrosis","volume":"21","author":"G\u00fcnther","year":"2012","journal-title":"Eur. Respir. Rev."},{"issue":"1","key":"10.1016\/j.rmed.2025.108519_bib16","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1164\/ajrccm.155.1.9001319","article-title":"Cigarette smoking: a risk factor for idiopathic pulmonary fibrosis","volume":"155","author":"Baumgartner","year":"1997","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2025.108519_bib17","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1146\/annurev-pathol-012513-104706","article-title":"Pathogenesis of idiopathic pulmonary fibrosis","volume":"9","author":"Wolters","year":"2014","journal-title":"Annu. Rev. Pathol."},{"issue":"1","key":"10.1016\/j.rmed.2025.108519_bib18","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3181\/00379727-214-44066","article-title":"Role of transforming growth factor-\u03b2 in tissue injury and repair","volume":"214","author":"Grande","year":"1997","journal-title":"Proc. Soc. Exp. Biol. Med."},{"issue":"5","key":"10.1016\/j.rmed.2025.108519_bib19","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1128\/MCB.00586-15","article-title":"SIRT3 blocks aging-associated tissue fibrosis in mice by deacetylating and activating glycogen synthase kinase 3\u03b2","volume":"36","author":"Sundaresan","year":"2016","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.rmed.2025.108519_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118201","article-title":"Sirtuins as endogenous regulators of lung fibrosis: a current perspective","volume":"258","author":"Mazumder","year":"2020","journal-title":"Life Sci."},{"issue":"5","key":"10.1016\/j.rmed.2025.108519_bib21","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1006\/cbir.2002.0901","article-title":"Direct evidence for a role of \u03b2-catenin\/LEF-1 signaling pathway in induction of EMT","volume":"26","author":"Kim","year":"2002","journal-title":"Cell Biol. Int."},{"issue":"7","key":"10.1016\/j.rmed.2025.108519_bib22","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/ng.157","article-title":"A Gata6\u2013Wnt pathway required for epithelial stem cell development and airway regeneration","volume":"40","author":"Zhang","year":"2008","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.rmed.2025.108519_bib23","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1755-1536-7-14","article-title":"Secreted frizzled related proteins inhibit fibrosis in vitro but appear redundant in vivo","volume":"7","author":"De Langhe","year":"2014","journal-title":"Fibrogenesis Tissue Repair"},{"issue":"5","key":"10.1016\/j.rmed.2025.108519_bib24","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/S0002-9440(10)64282-4","article-title":"Aberrant Wnt\/\u03b2-catenin pathway activation in idiopathic pulmonary fibrosis","volume":"162","author":"Chilosi","year":"2003","journal-title":"Am. J. Pathol."},{"issue":"9","key":"10.1016\/j.rmed.2025.108519_bib25","doi-asserted-by":"crossref","first-page":"6292","DOI":"10.1073\/pnas.092134099","article-title":"Gene expression analysis reveals matrilysin as a key regulator of pulmonary fibrosis in mice and humans","volume":"99","author":"Zuo","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"issue":"23","key":"10.1016\/j.rmed.2025.108519_bib26","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1101\/gad.938601","article-title":"Hedgehog signaling in animal development: paradigms and principles","volume":"15","author":"Ingham","year":"2001","journal-title":"Genes Dev."},{"issue":"11","key":"10.1016\/j.rmed.2025.108519_bib27","doi-asserted-by":"crossref","first-page":"L978","DOI":"10.1152\/ajplung.00184.2012","article-title":"Role of Sonic Hedgehog in idiopathic pulmonary fibrosis","volume":"303","author":"Bola\u00f1os","year":"2012","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.rmed.2025.108519_bib28","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/978-1-4614-0899-4_7","article-title":"Notch signaling in lung development and disease","volume":"727","author":"Xu","year":"2012","journal-title":"Notch Signal. Embryol. Cancer"},{"issue":"11","key":"10.1016\/j.rmed.2025.108519_bib29","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/nrm.2016.94","article-title":"Notch signalling in context","volume":"17","author":"Bray","year":"2016","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"11","key":"10.1016\/j.rmed.2025.108519_bib30","doi-asserted-by":"crossref","first-page":"3066","DOI":"10.1016\/j.ajpath.2015.07.014","article-title":"Mesenchymal deficiency of Notch1 attenuates bleomycin-induced pulmonary fibrosis","volume":"185","author":"Hu","year":"2015","journal-title":"Am. J. Pathol."},{"issue":"14","key":"10.1016\/j.rmed.2025.108519_bib31","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1101\/gad.266551.115","article-title":"Fibroblast growth factor signaling in skeletal development and disease","volume":"29","author":"Ornitz","year":"2015","journal-title":"Genes Dev."},{"key":"10.1016\/j.rmed.2025.108519_bib32","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.mam.2018.08.004","article-title":"Developmental pathways in the pathogenesis of lung fibrosis","volume":"65","author":"Chanda","year":"2019","journal-title":"Mol. Aspect. Med."},{"issue":"22","key":"10.1016\/j.rmed.2025.108519_bib33","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1056\/NEJMoa1402584","article-title":"Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis","volume":"370","author":"Richeldi","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"25","key":"10.1016\/j.rmed.2025.108519_bib34","doi-asserted-by":"crossref","first-page":"10364","DOI":"10.1074\/jbc.M117.791764","article-title":"Pulmonary fibrosis requires cell-autonomous mesenchymal fibroblast growth factor (FGF) signaling","volume":"292","author":"Guzy","year":"2017","journal-title":"J. Biol. Chem."},{"issue":"9842","key":"10.1016\/j.rmed.2025.108519_bib35","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/S0140-6736(12)61144-1","article-title":"New cellular and molecular mechanisms of lung injury and fibrosis in idiopathic pulmonary fibrosis","volume":"380","author":"Fernandez","year":"2012","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.rmed.2025.108519_bib36","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1164\/rccm.201306-1141WS","article-title":"Future directions in idiopathic pulmonary fibrosis research. An NHLBI workshop report","volume":"189","author":"Blackwell","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2025.108519_bib37","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3389\/fmed.2018.00043","article-title":"The role of immune and inflammatory cells in idiopathic pulmonary fibrosis","volume":"5","author":"Desai","year":"2018","journal-title":"Front. Med."},{"issue":"6","key":"10.1016\/j.rmed.2025.108519_bib38","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1164\/rccm.201308-1483ST","article-title":"An official ATS\/ERS statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias","volume":"188","author":"Travis","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"6","key":"10.1016\/j.rmed.2025.108519_bib39","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1164\/rccm.2009-040GL","article-title":"An official ATS\/ERS\/JRS\/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management","volume":"183","author":"Raghu","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"9","key":"10.1016\/j.rmed.2025.108519_bib40","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1164\/rccm.200709-1446OC","article-title":"Treatment of idiopathic pulmonary fibrosis with etanercept: an exploratory, placebo-controlled trial","volume":"178","author":"Raghu","year":"2008","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"4","key":"10.1016\/j.rmed.2025.108519_bib41","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1513\/pats.200601-003TK","article-title":"Role of epithelial cells in idiopathic pulmonary fibrosis: from innocent targets to serial killers","volume":"3","author":"Selman","year":"2006","journal-title":"Proc. Am. Thorac. Soc."},{"issue":"9","key":"10.1016\/j.rmed.2025.108519_bib42","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1164\/rccm.202202-0399ST","article-title":"Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: an official ATS\/ERS\/JRS\/ALAT clinical practice guideline","volume":"205","author":"Raghu","year":"2022","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.rmed.2025.108519_bib43","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s12931-018-0864-2","article-title":"Macrophages: friend or foe in idiopathic pulmonary fibrosis?","volume":"19","author":"Zhang","year":"2018","journal-title":"Respir. Res."},{"issue":"240","key":"10.1016\/j.rmed.2025.108519_bib44","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3007096","article-title":"Chitinase 3-like 1 suppresses injury and promotes fibroproliferative responses in mammalian lung fibrosis","volume":"6","author":"Zhou","year":"2014","journal-title":"Sci. Transl. Med."},{"issue":"50","key":"10.1016\/j.rmed.2025.108519_bib45","doi-asserted-by":"crossref","first-page":"38376","DOI":"10.1074\/jbc.M605146200","article-title":"Apoptotic cells, through transforming growth factor-\u03b2, coordinately induce anti-inflammatory and suppress pro-inflammatory eicosanoid and NO synthesis in murine macrophages","volume":"281","author":"Freire-de-Lima","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.rmed.2025.108519_bib46","first-page":"491","article-title":"Macrophage cytokines: involvement in immunity and infectious diseases","volume":"5","author":"Arango","year":"2014","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.rmed.2025.108519_bib47","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1164\/rccm.201603-0568OC","article-title":"Differential expression of VEGF-Axxx isoforms is critical for development of pulmonary fibrosis","volume":"196","author":"Barratt","year":"2017","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"16","key":"10.1016\/j.rmed.2025.108519_bib48","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.92192","article-title":"Antifibrotic role of vascular endothelial growth factor in pulmonary fibrosis","volume":"2","author":"Murray","year":"2017","journal-title":"JCI Insight"},{"issue":"5","key":"10.1016\/j.rmed.2025.108519_bib49","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1378\/chest.112.5.1338","article-title":"The role of neutrophils in the pathogenesis of idiopathic pulmonary fibrosis","volume":"112","author":"Obayashi","year":"1997","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.rmed.2025.108519_bib50","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1467-2494.2004.00241.x","article-title":"Ultraviolet radiation and skin aging: roles of reactive oxygen species, inflammation and protease activation, and strategies for prevention of inflammation-induced matrix degradation - a review","volume":"27","author":"Pillai","year":"2005","journal-title":"Int. J. Cosmet. Sci."},{"issue":"48","key":"10.1016\/j.rmed.2025.108519_bib51","doi-asserted-by":"crossref","first-page":"29987","DOI":"10.1074\/jbc.272.48.29987","article-title":"Evolutionary divergence of substrate specificity within the chymotrypsin-like serine protease fold","volume":"272","author":"Perona","year":"1997","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.rmed.2025.108519_bib52","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1189\/jlb.3HI1014-493R","article-title":"Neutrophil elastase promotes myofibroblast differentiation in lung fibrosis","volume":"98","author":"Gregory","year":"2015","journal-title":"J. Leukoc. Biol."},{"issue":"6","key":"10.1016\/j.rmed.2025.108519_bib53","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/nri2990","article-title":"Fibrocytes: emerging effector cells in chronic inflammation","volume":"11","author":"Reilkoff","year":"2011","journal-title":"Nat. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.rmed.2025.108519_bib54","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s11926-006-0055-x","article-title":"The role of circulating fibrocytes in fibrosis","volume":"8","author":"Quan","year":"2006","journal-title":"Curr. Rheumatol. Rep."},{"issue":"1","key":"10.1016\/j.rmed.2025.108519_bib55","doi-asserted-by":"crossref","first-page":"419","DOI":"10.4049\/jimmunol.160.1.419","article-title":"Regulated production of type I collagen and inflammatory cytokines by peripheral blood fibrocytes","volume":"160","author":"Chesney","year":"1998","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.rmed.2025.108519_bib56","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/jlb.65.2.187","article-title":"T cell independence of bleomycin-induced pulmonary fibrosis","volume":"65","author":"Helene","year":"1999","journal-title":"J. Leukoc. Biol."},{"issue":"3","key":"10.1016\/j.rmed.2025.108519_bib57","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1183\/09031936.98.11030706","article-title":"Predictive value of response to treatment of T-lymphocyte subpopulations in idiopathic pulmonary fibrosis","volume":"11","author":"Fireman","year":"1998","journal-title":"Eur. Respir. J."},{"issue":"7","key":"10.1016\/j.rmed.2025.108519_bib58","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/icb.2017.22","article-title":"Idiopathic pulmonary fibrosis and a role for autoimmunity","volume":"95","author":"Hoyne","year":"2017","journal-title":"Immunol. Cell Biol."},{"issue":"2","key":"10.1016\/j.rmed.2025.108519_bib59","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1189\/jlb.0707504","article-title":"Roles of T lymphocytes in pulmonary fibrosis","volume":"83","author":"Luzina","year":"2008","journal-title":"J. Leukoc. Biol."},{"issue":"6","key":"10.1016\/j.rmed.2025.108519_bib60","first-page":"378","article-title":"Change of prostaglandin E2 and interleukin-12, interleukin-13 in the bronchoalveolar lavage fluid and the serum of the patients with idiopathic pulmonary fibrosis","volume":"27","author":"Li","year":"2004","journal-title":"Zhonghua Jie He He Hu Xi Za Zhi"},{"issue":"2","key":"10.1016\/j.rmed.2025.108519_bib61","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1159\/000073718","article-title":"Potential action of IL-4 and IL-13 as fibrogenic factors on lung fibroblasts in vitro","volume":"132","author":"Saito","year":"2003","journal-title":"Int. Arch. Allergy Immunol."},{"issue":"2","key":"10.1016\/j.rmed.2025.108519_bib62","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJMoa030511","article-title":"A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis","volume":"350","author":"Raghu","year":"2004","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.rmed.2025.108519_bib63","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1164\/rccm.201704-0784OC","article-title":"A phase 2 randomized controlled study of tralokinumab in subjects with idiopathic pulmonary fibrosis","volume":"197","author":"Parker","year":"2018","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2025.108519_bib64","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2147\/JIR.S40673","article-title":"Lymphocyte aggregates persist and accumulate in the lungs of patients with idiopathic pulmonary fibrosis","volume":"6","author":"Todd","year":"2013","journal-title":"J. Inflamm. Res."},{"issue":"5","key":"10.1016\/j.rmed.2025.108519_bib65","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.4049\/jimmunol.1700473","article-title":"Autoimmunity to vimentin is associated with outcomes of patients with idiopathic pulmonary fibrosis","volume":"199","author":"Li","year":"2017","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.rmed.2025.108519_bib66","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1164\/rccm.201203-0506OC","article-title":"Patients with idiopathic pulmonary fibrosis with antibodies to heat shock protein 70 have poor prognoses","volume":"187","author":"Kahloon","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2025.108519_bib67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2014.08.003","article-title":"B cell activating factor is central to bleomycin- and IL-17-mediated experimental pulmonary fibrosis","volume":"56","author":"Fran\u00e7ois","year":"2015","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.rmed.2025.108519_bib68","first-page":"25","article-title":"Plasmapheresis for the treatment of idiopathic pulmonary fibrosis","volume":"5","author":"Voinov","year":"2019","journal-title":"J. Pulm Med. Respir. Res."},{"issue":"7","key":"10.1016\/j.rmed.2025.108519_bib69","first-page":"552","article-title":"Adverse reactions of amiodarone","volume":"16","author":"Colunga Biancatelli","year":"2019","journal-title":"J. Geriatr. Cardiol."},{"issue":"7","key":"10.1016\/j.rmed.2025.108519_bib70","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1080\/10520295.2017.1350750","article-title":"The role of mast cells and macrophages in amiodarone induced pulmonary fibrosis and the possible attenuating role of atorvastatin","volume":"92","author":"El-Mohandes","year":"2017","journal-title":"Biotech. Histochem."},{"key":"10.1016\/j.rmed.2025.108519_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.108889","article-title":"Amiodarone induces cell proliferation and myofibroblast differentiation via ERK1\/2 and p38 MAPK signaling in fibroblasts","volume":"115","author":"Weng","year":"2019","journal-title":"Biomed. Pharmacother."},{"issue":"2\u20133","key":"10.1016\/j.rmed.2025.108519_bib72","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S1567-5769(01)00172-2","article-title":"Diseases caused by asbestos: mechanisms of injury and disease development","volume":"2","author":"Manning","year":"2002","journal-title":"Int. Immunopharmacol."},{"issue":"2","key":"10.1016\/j.rmed.2025.108519_bib73","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1172\/JCI87440","article-title":"Mitochondria in the spotlight of aging and idiopathic pulmonary fibrosis","volume":"127","author":"Mora","year":"2017","journal-title":"J. Clin. Investig."},{"issue":"1","key":"10.1016\/j.rmed.2025.108519_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100810","article-title":"NOX4 regulates macrophage apoptosis resistance to induce fibrotic progression","volume":"297","author":"Larson-Casey","year":"2021","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.rmed.2025.108519_bib75","doi-asserted-by":"crossref","DOI":"10.5620\/eht.e2018014","article-title":"A review of current studies on cellular and molecular mechanisms underlying pulmonary fibrosis induced by chemicals","volume":"33","author":"Kim","year":"2018","journal-title":"Environ. Health Toxicol."},{"issue":"1","key":"10.1016\/j.rmed.2025.108519_bib76","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-14612-5","article-title":"Involvement of ER stress, PI3K\/AKT activation, and lung fibroblast proliferation in bleomycin-induced pulmonary fibrosis","volume":"7","author":"Hsu","year":"2017","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.rmed.2025.108519_bib77","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1517\/14740330903066734","article-title":"Mechanisms underlying methotrexate-induced pulmonary toxicity","volume":"8","author":"Kim","year":"2009","journal-title":"Expet Opin. Drug Saf."},{"issue":"3","key":"10.1016\/j.rmed.2025.108519_bib78","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s43188-020-00067-w","article-title":"Differential mechanisms underlying methotrexate-induced cell death and epithelial-mesenchymal transition in A549 cells","volume":"37","author":"Ojima","year":"2021","journal-title":"Toxicol. Res."},{"key":"10.1016\/j.rmed.2025.108519_bib79","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.taap.2018.06.020","article-title":"Vitamin D treatment abrogates the inflammatory response in paraquat-induced lung fibrosis","volume":"355","author":"Schapochnik","year":"2018","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"1","key":"10.1016\/j.rmed.2025.108519_bib80","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1080\/10408444.2020.1864721","article-title":"The herbicide paraquat-induced molecular mechanisms in the development of acute lung injury and lung fibrosis","volume":"51","author":"Subbiah","year":"2021","journal-title":"Crit. Rev. Toxicol."},{"issue":"3","key":"10.1016\/j.rmed.2025.108519_bib81","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1189\/jlb.0807533","article-title":"The IL-4R\u03b1 pathway in macrophages and its potential role in silica-induced pulmonary fibrosis","volume":"83","author":"Migliaccio","year":"2008","journal-title":"J. Leukoc. Biol."},{"issue":"17","key":"10.1016\/j.rmed.2025.108519_bib82","doi-asserted-by":"crossref","first-page":"4255","DOI":"10.7150\/thno.20270","article-title":"Dioscin exerts protective effects against crystalline silica-induced pulmonary fibrosis in mice","volume":"7","author":"Li","year":"2017","journal-title":"Theranostics"},{"issue":"2","key":"10.1016\/j.rmed.2025.108519_bib83","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1093\/toxsci\/kfy221","article-title":"The CDR1as\/miR-7\/TGFBR2 axis modulates EMT in silica-induced pulmonary fibrosis","volume":"166","author":"Yao","year":"2018","journal-title":"Toxicol. Sci."},{"issue":"3","key":"10.1016\/j.rmed.2025.108519_bib84","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.ccm.2004.04.004","article-title":"Occupational interstitial lung disease","volume":"25","author":"Glazer","year":"2004","journal-title":"Clin. Chest Med."},{"key":"10.1016\/j.rmed.2025.108519_bib85","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s12011-008-8143-6","article-title":"Analysis of trace elements in bronchoalveolar lavage of patients with diffuse lung diseases","volume":"124","author":"Bargagli","year":"2008","journal-title":"Biol. Trace Elem. Res."},{"key":"10.1016\/j.rmed.2025.108519_bib86","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12931-016-0343-6","article-title":"Role of matrix metalloproteinases in the pathogenesis of idiopathic pulmonary fibrosis","volume":"17","author":"Pardo","year":"2016","journal-title":"Respir. Res."},{"issue":"3","key":"10.1016\/j.rmed.2025.108519_bib87","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3109\/15376516.2012.753967","article-title":"Pulmonary toxicity and fibrogenic response of carbon nanotubes","volume":"23","author":"Manke","year":"2013","journal-title":"Toxicol. Mech. Methods"},{"issue":"2","key":"10.1016\/j.rmed.2025.108519_bib88","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s40572-018-0192-1","article-title":"A meta-analysis of arsenic exposure and lung function: is there evidence of restrictive or obstructive lung disease?","volume":"5","author":"Sanchez","year":"2018","journal-title":"Curr. Environ. Health Rep."},{"issue":"2","key":"10.1016\/j.rmed.2025.108519_bib89","doi-asserted-by":"crossref","first-page":"169","DOI":"10.4103\/0970-2113.152640","article-title":"Unexplained dyspnea in a patient of chronic arsenicosis: a diagnostic challenge and learning curve for physicians","volume":"32","author":"Sengupta","year":"2015","journal-title":"Lung India"},{"issue":"6","key":"10.1016\/j.rmed.2025.108519_bib90","first-page":"360","article-title":"Systemic arterial disease and chronic arsenicism in infants","volume":"97","author":"Rosenberg","year":"1974","journal-title":"Arch. Pathol."},{"issue":"1","key":"10.1016\/j.rmed.2025.108519_bib91","first-page":"4","article-title":"Chronic arsenic toxicity in West Bengal\u2014The worst calamity in the world","volume":"96","author":"Mazumder","year":"1998","journal-title":"J. Indian Med. Assoc."},{"issue":"3","key":"10.1016\/j.rmed.2025.108519_bib92","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.taap.2012.08.028","article-title":"Sulforaphane prevents pulmonary damage in response to inhaled arsenic by activating the Nrf2-defense response","volume":"265","author":"Zheng","year":"2012","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"8","key":"10.1016\/j.rmed.2025.108519_bib93","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/S0046-8177(82)80291-8","article-title":"Desquamative interstitial pneumonia in an aluminum welder","volume":"13","author":"Herbert","year":"1982","journal-title":"Hum. Pathol."},{"issue":"2","key":"10.1016\/j.rmed.2025.108519_bib94","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1164\/arrd.1984.130.2.312","article-title":"Pulmonary alveolar proteinosis and aluminum dust exposure","volume":"130","author":"Miller","year":"1984","journal-title":"Am. Rev. Respir. Dis."},{"issue":"2","key":"10.1016\/j.rmed.2025.108519_bib95","first-page":"493","article-title":"Sarcoidlike lung granulomatosis induced by aluminum dusts","volume":"135","author":"De Vuyst","year":"1987","journal-title":"Am. Rev. Respir. Dis."},{"issue":"5","key":"10.1016\/j.rmed.2025.108519_bib96","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s004080000069","article-title":"The effect of experimental pleurodesis caused by aluminum hydroxide on lung and chest wall mechanics","volume":"179","author":"Albuquerque","year":"2001","journal-title":"Lung"},{"issue":"4","key":"10.1016\/j.rmed.2025.108519_bib97","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s40572-018-0219-7","article-title":"Metal-induced pulmonary fibrosis","volume":"5","author":"Assad","year":"2018","journal-title":"Curr. Environ. Health Rep."},{"issue":"Suppl 4","key":"10.1016\/j.rmed.2025.108519_bib98","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1289\/ehp.00108s4685","article-title":"Inorganic dust pneumonias: the metal-related parenchymal disorders","volume":"108","author":"Kelleher","year":"2000","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.rmed.2025.108519_bib99","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/5928572","article-title":"Association between the type of workplace and lung function in copper miners","volume":"2016","author":"Skoczy\u0144ska","year":"2016","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.rmed.2025.108519_bib100","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2023.1331134","article-title":"Air pollution exposure and its effects on idiopathic pulmonary fibrosis: clinical worsening, lung function decline, and radiological deterioration","volume":"11","author":"Mariscal-Aguilar","year":"2024","journal-title":"Front. Public Health"},{"issue":"1","key":"10.1016\/j.rmed.2025.108519_bib101","doi-asserted-by":"crossref","first-page":"4499","DOI":"10.1038\/s41598-018-22556-7","article-title":"Intranasal delivery of copper oxide nanoparticles induces pulmonary toxicity and fibrosis in C57BL\/6 mice","volume":"8","author":"Lai","year":"2018","journal-title":"Sci. Rep."},{"issue":"1\u20134","key":"10.1016\/j.rmed.2025.108519_bib102","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1093\/oxfordjournals.rpd.a006214","article-title":"Characterisation and dissolution of depleted uranium aerosols produced during impacts of kinetic energy penetrators against a tank","volume":"105","author":"Chazel","year":"2003","journal-title":"Radiat. Protect. Dosim."},{"issue":"10","key":"10.1016\/j.rmed.2025.108519_bib103","doi-asserted-by":"crossref","first-page":"575","DOI":"10.3390\/toxics10100575","article-title":"Health effects of particulate uranium exposure","volume":"10","author":"Zhang","year":"2022","journal-title":"Toxics"},{"issue":"1","key":"10.1016\/j.rmed.2025.108519_bib104","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.taap.2003.08.016","article-title":"Uranium induces TNF\u03b1 secretion and MAPK activation in a rat alveolar macrophage cell line","volume":"194","author":"Gazin","year":"2004","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"5","key":"10.1016\/j.rmed.2025.108519_bib105","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1159\/000356958","article-title":"Idiopathic pulmonary fibrosis: recent trials and current drug therapy","volume":"86","author":"Jones","year":"2013","journal-title":"Respiration"},{"issue":"11","key":"10.1016\/j.rmed.2025.108519_bib106","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S2213-2600(14)70232-2","article-title":"Combination therapy: the future of management for idiopathic pulmonary fibrosis?","volume":"2","author":"Wuyts","year":"2014","journal-title":"Lancet Respir. Med."},{"issue":"1","key":"10.1016\/j.rmed.2025.108519_bib107","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-48593-4","article-title":"Gastrointestinal adverse effects of nintedanib and the associated risk factors in patients with idiopathic pulmonary fibrosis","volume":"9","author":"Kato","year":"2019","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.rmed.2025.108519_bib108","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/S0002-9343(00)00711-7","article-title":"Steroids in idiopathic pulmonary fibrosis: a prospective assessment of adverse reactions, response to therapy, and survival","volume":"110","author":"Flaherty","year":"2001","journal-title":"Am. J. Med."},{"issue":"2","key":"10.1016\/j.rmed.2025.108519_bib109","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1164\/rccm.201902-0456OC","article-title":"Clinical effectiveness of antifibrotic medications for idiopathic pulmonary fibrosis","volume":"200","author":"Dempsey","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"4","key":"10.1016\/j.rmed.2025.108519_bib110","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1152\/physrev.00004.2016","article-title":"Idiopathic pulmonary fibrosis: a genetic disease that involves mucociliary dysfunction of the peripheral airways","volume":"96","author":"Evans","year":"2016","journal-title":"Physiol. Rev."},{"issue":"5","key":"10.1016\/j.rmed.2025.108519_bib111","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1183\/09031936.00073012","article-title":"The pathogenesis of pulmonary fibrosis: a moving target","volume":"41","author":"Wuyts","year":"2013","journal-title":"Eur. Respir. J."},{"issue":"4","key":"10.1016\/j.rmed.2025.108519_bib112","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.jaci.2017.07.001","article-title":"Promising approaches for the treatment and prevention of viral respiratory illnesses","volume":"140","author":"Papadopoulos","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"issue":"6","key":"10.1016\/j.rmed.2025.108519_bib113","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1039\/C9NP00011A","article-title":"Synergy and antagonism in natural product extracts: when 1+1 does not equal 2","volume":"36","author":"Caesar","year":"2019","journal-title":"Nat. Prod. Rep."},{"issue":"6","key":"10.1016\/j.rmed.2025.108519_bib114","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/j.biotechadv.2018.04.001","article-title":"Naturally occurring compounds in differentiation based therapy of cancer","volume":"36","author":"Mijatovi\u0107","year":"2018","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.rmed.2025.108519_bib115","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/9274246","article-title":"The effects of sinapic acid on the development of metabolic disorders induced by estrogen deficiency in rats","volume":"2018","author":"Zych","year":"2018","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"1","key":"10.1016\/j.rmed.2025.108519_bib116","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1073\/pnas.1315854111","article-title":"IL-25 and type 2 innate lymphoid cells induce pulmonary fibrosis","volume":"111","author":"Hams","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.rmed.2025.108519_bib117","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107500","article-title":"Targeting defective pulmonary innate immunity \u2013 a new therapeutic option?","volume":"209","author":"Belchamber","year":"2020","journal-title":"Pharmacol. Ther."},{"issue":"6","key":"10.1016\/j.rmed.2025.108519_bib118","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1017\/S0007114515002597","article-title":"Protective effect of polyphenols in an inflammatory process associated with experimental pulmonary fibrosis in mice","volume":"114","author":"Impellizzeri","year":"2015","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.rmed.2025.108519_bib119","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110119","article-title":"Juglanin alleviates bleomycin-induced lung injury by suppressing inflammation and fibrosis via targeting STING signaling","volume":"127","author":"Sun","year":"2020","journal-title":"Biomed. Pharmacother."},{"issue":"22","key":"10.1016\/j.rmed.2025.108519_bib120","doi-asserted-by":"crossref","first-page":"11653","DOI":"10.1021\/jf1031668","article-title":"Luteolin ameliorates experimental lung fibrosis both in vivo and in vitro: implications for therapy of lung fibrosis","volume":"58","author":"Chen","year":"2010","journal-title":"J. Agric. Food Chem."},{"issue":"1","key":"10.1016\/j.rmed.2025.108519_bib121","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3892\/ijmm.2014.1745","article-title":"The green tea extract epigallocatechin-3-gallate inhibits irradiation-induced pulmonary fibrosis in adult rats","volume":"34","author":"You","year":"2014","journal-title":"Int. J. Mol. Med."},{"issue":"6","key":"10.1016\/j.rmed.2025.108519_bib122","doi-asserted-by":"crossref","first-page":"4190","DOI":"10.3892\/mmr.2015.3333","article-title":"Tanshinone IIA attenuates bleomycin-induced pulmonary fibrosis in rats","volume":"11","author":"He","year":"2015","journal-title":"Mol. Med. Rep."},{"issue":"3","key":"10.1016\/j.rmed.2025.108519_bib123","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1055\/s-2005-837821","article-title":"Inhibitory effects of isoliensinine on bleomycin-induced pulmonary fibrosis in mice","volume":"71","author":"Xiao","year":"2005","journal-title":"Planta Med."},{"issue":"18","key":"10.1016\/j.rmed.2025.108519_bib124","doi-asserted-by":"crossref","first-page":"4422","DOI":"10.3390\/ijms20184422","article-title":"Coelonin, an anti-inflammation active component of Bletilla striata and its potential mechanism","volume":"20","author":"Jiang","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.rmed.2025.108519_bib125","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.cbi.2015.06.019","article-title":"Effect of glycosides based standardized fenugreek seed extract in bleomycin-induced pulmonary fibrosis in rats: decisive role of Bax, Nrf2, NF-\u03baB, Muc5ac, TNF-\u03b1 and IL-1\u03b2","volume":"237","author":"Kandhare","year":"2015","journal-title":"Chem. Biol. Interact."},{"issue":"2","key":"10.1016\/j.rmed.2025.108519_bib126","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1039\/C7TX00304H","article-title":"Bixin protects against particle-induced long-term lung injury in an NRF2-dependent manner","volume":"7","author":"Xue","year":"2018","journal-title":"Toxicol. Res."},{"issue":"5","key":"10.1016\/j.rmed.2025.108519_bib127","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.freeradbiomed.2010.04.036","article-title":"Oxidative stress, extracellular matrix targets, and idiopathic pulmonary fibrosis","volume":"49","author":"Kliment","year":"2010","journal-title":"Free Radic. Biol. Med."},{"issue":"2","key":"10.1016\/j.rmed.2025.108519_bib128","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41419-017-0198-x","article-title":"Nrf2 antioxidant pathway suppresses Numb-mediated epithelial\u2013mesenchymal transition during pulmonary fibrosis","volume":"9","author":"Zhang","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.rmed.2025.108519_bib129","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/j.2040-4603.2020.tb00120.x","article-title":"Oxidative stress in pulmonary fibrosis","volume":"10","author":"Otoupalova","year":"2020","journal-title":"Compr. Physiol."},{"key":"10.1016\/j.rmed.2025.108519_bib130","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1007\/s12013-014-0295-8","article-title":"Effects of lettuce glycoside B in ameliorating pulmonary fibrosis induced by irradiation exposure and its anti-OS mechanism","volume":"71","author":"Zhou","year":"2015","journal-title":"Cell Biochem. Biophys."},{"issue":"6","key":"10.1016\/j.rmed.2025.108519_bib131","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.pharep.2015.03.012","article-title":"Protective effect of gallic acid against bleomycin-induced pulmonary fibrosis in rats","volume":"67","author":"Nikbakht","year":"2015","journal-title":"Pharmacol. Rep."},{"issue":"5","key":"10.1016\/j.rmed.2025.108519_bib132","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1080\/01635581.2018.1521442","article-title":"Effect of Phoenix dactylifera L. sap against bleomycin-induced pulmonary fibrosis and OS in rats: phytochemical and therapeutic assessment","volume":"71","author":"Bahri","year":"2019","journal-title":"Nutr. Cancer"},{"issue":"4","key":"10.1016\/j.rmed.2025.108519_bib133","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.clnu.2014.08.014","article-title":"Resveratrol ameliorates lipopolysaccharide-induced epithelial mesenchymal transition and pulmonary fibrosis through suppression of OS and transforming growth factor-\u03b21 signaling","volume":"34","author":"Zhang","year":"2015","journal-title":"Clin. Nutr."},{"issue":"1","key":"10.1016\/j.rmed.2025.108519_bib134","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1080\/13880209.2016.1247881","article-title":"Prophylactic and curative effect of rosemary leaves extract in a bleomycin model of pulmonary fibrosis","volume":"55","author":"Bahri","year":"2017","journal-title":"Pharm. Biol."},{"issue":"231","key":"10.1016\/j.rmed.2025.108519_bib135","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3008182","article-title":"Reversal of persistent fibrosis in aging by targeting Nox4-Nrf2 redox imbalance","volume":"6","author":"Hecker","year":"2014","journal-title":"Sci. Transl. Med."},{"issue":"5","key":"10.1016\/j.rmed.2025.108519_bib136","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1142\/S0192415X19500575","article-title":"Salvia miltiorrhiza restrains reactive oxygen species-associated pulmonary fibrosis via targeting Nrf2-Nox4 redox balance","volume":"47","author":"Peng","year":"2019","journal-title":"Am. J. Chin. Med."},{"key":"10.1016\/j.rmed.2025.108519_bib137","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1007\/s10753-018-0743-5","article-title":"Possible modulatory effect of tamarind seed coat extract on fluoride-induced pulmonary inflammation and fibrosis in rats","volume":"41","author":"Ameeramja","year":"2018","journal-title":"Inflammation"},{"key":"10.1016\/j.rmed.2025.108519_bib138","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1007\/s10495-017-1393-z","article-title":"Amelioration of bleomycin-induced pulmonary fibrosis by chlorogenic acid through endoplasmic reticulum stress inhibition","volume":"22","author":"Wang","year":"2017","journal-title":"Apoptosis"},{"issue":"10","key":"10.1016\/j.rmed.2025.108519_bib139","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1111\/jphp.12596","article-title":"Hydroxysafflor yellow A inhibits TGF-\u03b21-induced activation of human fetal lung fibroblasts in vitro","volume":"68","author":"Pan","year":"2016","journal-title":"J. Pharm. Pharmacol."},{"issue":"35","key":"10.1016\/j.rmed.2025.108519_bib140","doi-asserted-by":"crossref","first-page":"9789","DOI":"10.1021\/acs.jafc.9b02730","article-title":"Effects of \u03b2-Sitosterol from corn silk on TGF-\u03b21-induced epithelial\u2013mesenchymal transition in lung alveolar epithelial cells","volume":"67","author":"Park","year":"2019","journal-title":"J. Agric. Food Chem."},{"issue":"3","key":"10.1016\/j.rmed.2025.108519_bib141","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1039\/D0FO03001E","article-title":"The role of natural products in the prevention and treatment of pulmonary fibrosis: a review","volume":"12","author":"Wang","year":"2021","journal-title":"Food Funct."},{"key":"10.1016\/j.rmed.2025.108519_bib142","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.toxlet.2017.03.012","article-title":"Grape seed extract ameliorates bleomycin-induced mouse pulmonary fibrosis","volume":"273","author":"Liu","year":"2017","journal-title":"Toxicol. Lett."},{"issue":"4","key":"10.1016\/j.rmed.2025.108519_bib143","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3109\/01902148.2014.895070","article-title":"The inhibitory effect of salvianolic acid B on TGF-\u03b21-induced proliferation and differentiation in lung fibroblasts","volume":"40","author":"Zhang","year":"2014","journal-title":"Exp. Lung Res."},{"issue":"3","key":"10.1016\/j.rmed.2025.108519_bib144","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.jep.2013.08.017","article-title":"Paeoniflorin, the main active constituent of Paeonia lactiflora roots, attenuates bleomycin-induced pulmonary fibrosis in mice by suppressing the synthesis of type I collagen","volume":"149","author":"Ji","year":"2013","journal-title":"J. Ethnopharmacol."},{"issue":"1","key":"10.1016\/j.rmed.2025.108519_bib145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12890-016-0294-1","article-title":"Baicalin attenuates bleomycin-induced pulmonary fibrosis via adenosine A2a receptor related TGF-\u03b21-induced ERK1\/2 signaling pathway","volume":"16","author":"Huang","year":"2016","journal-title":"BMC Pulm. Med."},{"issue":"1","key":"10.1016\/j.rmed.2025.108519_bib146","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3390\/biom11010079","article-title":"Mangiferin as new potential anti-cancer agent and mangiferin-integrated polymer Systems-A novel research direction","volume":"11","author":"Morozkina","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.rmed.2025.108519_bib147","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2147\/NSA.S525423","article-title":"From nature to nanotechnology: the bioactivities of mangiferin explored","volume":"18","author":"Al-Madhagi","year":"2025","journal-title":"Nanotechnol. Sci. Appl."},{"issue":"2","key":"10.1016\/j.rmed.2025.108519_bib148","doi-asserted-by":"crossref","first-page":"40","DOI":"10.32607\/actanaturae.27440","article-title":"Dihydroquercetin-loaded liposomes change fibrous tissue distribution in the bleomycin-induced fibrosis model","volume":"16","author":"Ivanov","year":"2024","journal-title":"Acta Naturae (\u0430\u043d\u0433\u043b\u043e\u044f\u0437\u044b\u0447\u043d\u0430\u044f \u0432\u0435\u0440\u0441\u0438\u044f)"},{"key":"10.1016\/j.rmed.2025.108519_bib149","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1535555","article-title":"Luteolin: exploring its therapeutic potential and molecular mechanisms in pulmonary diseases","volume":"16","author":"Lv","year":"2025","journal-title":"Front. Pharmacol."},{"issue":"9","key":"10.1016\/j.rmed.2025.108519_bib150","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.3390\/pharmaceutics16091202","article-title":"Recent advancements in gallic acid-based drug delivery: applications, clinical trials, and future directions","volume":"16","author":"Harwansh","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.rmed.2025.108519_bib151","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.2147\/DDDT.S148868","article-title":"Resveratrol as a potential therapeutic drug for respiratory system diseases","volume":"11","author":"Zhu","year":"2017","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.rmed.2025.108519_bib152","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.2147\/IJN.S451206","article-title":"Natural products-based inhaled formulations for treating pulmonary diseases","volume":"19","author":"Yong","year":"2024","journal-title":"Int. J. Nanomed."},{"issue":"5","key":"10.1016\/j.rmed.2025.108519_bib153","doi-asserted-by":"crossref","first-page":"598","DOI":"10.3390\/ph17050598","article-title":"Exploring synergistic interactions between natural compounds and conventional chemotherapeutic drugs in preclinical models of lung cancer","volume":"17","author":"Bo\u021ba","year":"2024","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.rmed.2025.108519_bib154","article-title":"Dhumapana: ayurvedic herbal smoke therapy","author":"Sanjay","year":"2023","journal-title":"Int. Ayur Med. J."},{"issue":"4","key":"10.1016\/j.rmed.2025.108519_bib155","first-page":"236","article-title":"Exploring Dhumapana: the ancient art of Ayurvedic inhalation for health","volume":"9","author":"Somanath","year":"2024","journal-title":"J. Ayur Int. Med. Sci."},{"key":"10.1016\/j.rmed.2025.108519_bib156","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2019.105755","article-title":"Therapeutic effects of nimbolide, an autophagy regulator, in ameliorating pulmonary fibrosis through attenuation of TGF-\u03b21 driven epithelial-to-mesenchymal transition","volume":"75","author":"Prashanth Goud","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.rmed.2025.108519_bib157","first-page":"68","article-title":"Nimbolide: promising agent for prevention and treatment of chronic diseases (recent update)","volume":"18","author":"Rajendran","year":"2024","journal-title":"Food Nutr. Res."},{"issue":"5","key":"10.1016\/j.rmed.2025.108519_bib158","doi-asserted-by":"crossref","first-page":"L616","DOI":"10.1152\/ajplung.00002.2009","article-title":"Curcumin inhibits fibrosis-related effects in IPF fibroblasts and in mice following bleomycin-induced lung injury","volume":"298","author":"Smith","year":"2010","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"issue":"3","key":"10.1016\/j.rmed.2025.108519_bib159","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/s41401-020-0469-4","article-title":"Oral administration of curcumin ameliorates pulmonary fibrosis in mice through 15d-PGJ2-mediated induction of hepatocyte growth factor in the colon","volume":"42","author":"Miao","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.rmed.2025.108519_bib160","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1333715","article-title":"Capsaicin ameliorate pulmonary fibrosis via antioxidant Nrf-2\/PPAR- \u03b3 pathway activation and inflammatory TGF-\u03b21\/NF-\u03baB\/COX II pathway inhibition","volume":"15","author":"Abdulaal","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.rmed.2025.108519_bib161","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.888280","article-title":"The antifibrotic and the anticarcinogenic activity of capsaicin in hot chili pepper in relation to oral submucous fibrosis","volume":"13","author":"Huang","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.rmed.2025.108519_bib162","doi-asserted-by":"crossref","first-page":"104","DOI":"10.15586\/aei.v50i2.533","article-title":"6-Gingerol, a functional polyphenol of ginger, reduces pulmonary fibrosis by activating Sirtuin1","volume":"50","author":"Liu","year":"2022","journal-title":"Allergol. Immunopathol."},{"issue":"2","key":"10.1016\/j.rmed.2025.108519_bib163","doi-asserted-by":"crossref","first-page":"L296","DOI":"10.1152\/ajplung.00249.2019","article-title":"Ginger and its bioactive component 6-shogaol mitigate lung inflammation in a murine asthma model","volume":"318","author":"Yocum","year":"2020","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"issue":"9","key":"10.1016\/j.rmed.2025.108519_bib164","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1007\/s00210-020-01881-7","article-title":"Zingerone ameliorates oxidative stress and inflammation in bleomycin-induced pulmonary fibrosis: modulation of the expression of TGF-\u03b21 and iNOS","volume":"393","author":"Gungor","year":"2020","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"issue":"1","key":"10.1016\/j.rmed.2025.108519_bib165","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/s41598-023-27543-1","article-title":"Potential of hydroethanolic leaf extract of Ocimum sanctum in ameliorating redox status and lung injury in COPD: an in vivo and in silico study","volume":"13","author":"Srivastava","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.rmed.2025.108519_bib166","doi-asserted-by":"crossref","DOI":"10.1016\/j.prmcm.2022.100214","article-title":"Both eugenol and biseugenol treatments reduced lung alterations in an experimental model of elastase-induced pulmonary emphysema","volume":"6","author":"Taguchi","year":"2023","journal-title":"Pharmacol. Res. Modern Chin. Med."},{"issue":"3","key":"10.1016\/j.rmed.2025.108519_bib167","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/biof.1929","article-title":"Effects of rosmarinic acid, carnosic acid, rosmanol, carnosol, and ursolic acid on the pathogenesis of respiratory diseases","volume":"49","author":"Farhadi","year":"2023","journal-title":"Biofactors"},{"issue":"4","key":"10.1016\/j.rmed.2025.108519_bib168","doi-asserted-by":"crossref","DOI":"10.1177\/1559325820968413","article-title":"Rosmarinic acid prevents radiation-induced pulmonary fibrosis through attenuation of ROS\/MYPT1\/TGF\u03b21 signaling via miR-19b-3p","volume":"18","author":"Zhang","year":"2020","journal-title":"Dose Response"},{"issue":"1","key":"10.1016\/j.rmed.2025.108519_bib169","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1080\/13880209.2016.1247881","article-title":"Prophylactic and curative effect of rosemary leaves extract in a bleomycin model of pulmonary fibrosis","volume":"55","author":"Bahri","year":"2017","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.rmed.2025.108519_bib170","first-page":"5567","article-title":"Rosmarinic acid alleviates radiation-induced pulmonary fibrosis by downregulating the tRNA N7-methylguanosine modification-regulated fibroblast-to-myofibroblast transition through the exosome pathway","author":"Zhang","year":"2024","journal-title":"J. Inflamm. Res."},{"issue":"3","key":"10.1016\/j.rmed.2025.108519_bib171","doi-asserted-by":"crossref","first-page":"L526","DOI":"10.1152\/ajplung.00131.2002","article-title":"Intratracheal gene transfer of decorin reduces subpleural fibroproliferation induced by bleomycin","volume":"284","author":"Shimizukawa","year":"2003","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"issue":"4","key":"10.1016\/j.rmed.2025.108519_bib172","doi-asserted-by":"crossref","first-page":"L727","DOI":"10.1152\/ajplung.00209.2003","article-title":"Induction of CDK inhibitor p21 gene as a new therapeutic strategy against pulmonary fibrosis","volume":"286","author":"Inoshima","year":"2004","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"issue":"4","key":"10.1016\/j.rmed.2025.108519_bib173","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.bbrc.2005.11.127","article-title":"Intratracheal gene transfer of tissue factor pathway inhibitor attenuates pulmonary fibrosis","volume":"339","author":"Kijiyama","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"8","key":"10.1016\/j.rmed.2025.108519_bib174","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1164\/rccm.200912-1840OC","article-title":"The angiotensin-converting enzyme 2\/angiogenesis-(1\u20137)\/Mas axis confers cardiopulmonary protection against lung fibrosis and pulmonary hypertension","volume":"182","author":"Shenoy","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.rmed.2025.108519_bib175","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1172\/JCI6094","article-title":"Transient gene transfer and expression of Smad7 prevents bleomycin-induced lung fibrosis in mice","volume":"104","author":"Nakao","year":"1999","journal-title":"J. Clin. Investig."},{"issue":"6","key":"10.1016\/j.rmed.2025.108519_bib176","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/s41419-023-05889-8","article-title":"AAV9-Tspyl2 gene therapy retards bleomycin-induced pulmonary fibrosis by modulating downstream TGF-\u03b2 signaling in mice","volume":"14","author":"Zhang","year":"2023","journal-title":"Cell Death Dis."},{"issue":"6","key":"10.1016\/j.rmed.2025.108519_bib177","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02307-2021","article-title":"Bone morphogenetic protein 4 inhibits pulmonary fibrosis by modulating cellular senescence and mitophagy in lung fibroblasts","volume":"60","author":"Guan","year":"2022","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2025.108519_bib178","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.111456","article-title":"Regulation of miRNA-155-5p ameliorates NETosis in pulmonary fibrosis rat model via inhibiting its target cytokines IL-1\u03b2, TNF-\u03b1 and TGF-\u03b21","volume":"127","author":"Adel","year":"2024","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.rmed.2025.108519_bib179","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1186\/s13287-023-03581-4","article-title":"Induced pluripotent stem cells modulate the Wnt pathway in the bleomycin-induced model of idiopathic pulmonary fibrosis","volume":"14","author":"Bayati","year":"2023","journal-title":"Stem Cell Res. Ther."},{"issue":"3","key":"10.1016\/j.rmed.2025.108519_bib180","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1165\/rcmb.2011-0237OC","article-title":"MEK-ERK pathway modulation ameliorates pulmonary fibrosis associated with epidermal growth factor receptor activation","volume":"46","author":"Madala","year":"2012","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"6","key":"10.1016\/j.rmed.2025.108519_bib181","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.2353\/ajpath.2009.080954","article-title":"Gene expression profiling of pulmonary fibrosis identifies Twist1 as an antiapoptotic molecular \"rectifier\" of growth factor signaling","volume":"175","author":"Bridges","year":"2009","journal-title":"Am. J. Pathol."},{"issue":"14","key":"10.1016\/j.rmed.2025.108519_bib182","doi-asserted-by":"crossref","first-page":"7110","DOI":"10.7150\/thno.61085","article-title":"Local administration of liposomal-based Srpx2 gene therapy reverses pulmonary fibrosis by blockading fibroblast-to-myofibroblast transition","volume":"11","author":"Wang","year":"2021","journal-title":"Theranostics"},{"issue":"7","key":"10.1016\/j.rmed.2025.108519_bib183","doi-asserted-by":"crossref","first-page":"6695","DOI":"10.3390\/ijms24076695","article-title":"Amelioration of pulmonary fibrosis by matrix metalloproteinase-2 overexpression","volume":"24","author":"Inoue","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.rmed.2025.108519_bib184","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1089\/wound.2021.0077","article-title":"Inhibiting fibroblast mechanotransduction modulates severity of idiopathic pulmonary fibrosis","volume":"11","author":"Trotsyuk","year":"2022","journal-title":"Adv. Wound Care"},{"issue":"1","key":"10.1016\/j.rmed.2025.108519_bib185","doi-asserted-by":"crossref","first-page":"9044","DOI":"10.1038\/s41598-023-36009-3","article-title":"Overexpression of fatty acid synthase attenuates bleomycin-induced lung fibrosis by restoring mitochondrial dysfunction in mice","volume":"13","author":"Shin","year":"2023","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.rmed.2025.108519_bib186","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s41419-021-04365-5","article-title":"The histone methyltransferase DOT1L is a new epigenetic regulator of pulmonary fibrosis","volume":"13","author":"Yang","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.rmed.2025.108519_bib187","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1387197","article-title":"O-GlcNAc transferase regulates collagen deposition and fibrosis resolution in idiopathic pulmonary fibrosis","volume":"15","author":"Vang","year":"2024","journal-title":"Front. Immunol."},{"issue":"20","key":"10.1016\/j.rmed.2025.108519_bib188","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.152503","article-title":"Dysregulated overexpression of Sox9 induces fibroblast activation in pulmonary fibrosis","volume":"6","author":"Gajjala","year":"2021","journal-title":"JCI Insight"},{"issue":"2","key":"10.1016\/j.rmed.2025.108519_bib189","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10280","article-title":"Macrophage-targeted delivery of siRNA to silence Mecp2 gene expression attenuates pulmonary fibrosis","volume":"7","author":"Mou","year":"2022","journal-title":"Bioeng. Transl. Med."},{"issue":"51","key":"10.1016\/j.rmed.2025.108519_bib190","article-title":"A reduction in homeodomain interacting protein Kinase-2 in lung fibroblasts ameliorates lung fibrosis","volume":"38","author":"Hewawasam","year":"2023","journal-title":"Physiology"},{"issue":"1","key":"10.1016\/j.rmed.2025.108519_bib191","doi-asserted-by":"crossref","DOI":"10.1080\/15592294.2023.2195305","article-title":"LncRNA TUG1 promotes pulmonary fibrosis progression via up-regulating CDC27 and activating PI3K\/Akt\/mTOR pathway","volume":"18","author":"Qi","year":"2023","journal-title":"Epigenetics"},{"issue":"7","key":"10.1016\/j.rmed.2025.108519_bib192","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.ajpath.2021.04.006","article-title":"Targeting runt-related transcription factor 1 prevents pulmonary fibrosis and reduces expression of SARS-CoV-2 host mediators","volume":"191","author":"O'Hare","year":"2021","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.rmed.2025.108519_bib193","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nm1332","article-title":"IL-13 signaling through the IL-13\u03b12 receptor is involved in induction of TGF-\u03b21 production and fibrosis","volume":"12","author":"Fichtner-Feigl","year":"2006","journal-title":"Nat. Med."},{"issue":"9","key":"10.1016\/j.rmed.2025.108519_bib194","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1038\/nm.2005","article-title":"NADPH oxidase-4 mediates myofibroblast activation and fibrogenic responses to lung injury","volume":"15","author":"Hecker","year":"2009","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.rmed.2025.108519_bib195","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1136\/thx.2009.119974","article-title":"Suppression of plasminogen activator inhibitor-1 by RNA interference attenuates pulmonary fibrosis","volume":"65","author":"Senoo","year":"2010","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.rmed.2025.108519_bib196","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1620\/tjem.223.45","article-title":"Blockade of the Wnt\/\u03b2-catenin pathway attenuates bleomycin-induced pulmonary fibrosis","volume":"223","author":"Kim","year":"2011","journal-title":"Tohoku J. Exp. Med."},{"issue":"6","key":"10.1016\/j.rmed.2025.108519_bib197","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1016\/j.nano.2017.04.005","article-title":"Combinatorial treatment of idiopathic pulmonary fibrosis using nanoparticles with prostaglandin E and siRNA(s)","volume":"13","author":"Garbuzenko","year":"2017","journal-title":"Nanomedicine"},{"issue":"1","key":"10.1016\/j.rmed.2025.108519_bib198","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.115","article-title":"COVID-19: a systematic review and update on prevention, diagnosis, and treatment","volume":"3","author":"Aghamirza Moghim Aliabadi","year":"2022","journal-title":"MedComm"},{"issue":"6","key":"10.1016\/j.rmed.2025.108519_bib200","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1001\/jama.2020.12603","article-title":"Persistent symptoms in patients after acute COVID-19","volume":"324","author":"Carf\u00ec","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.rmed.2025.108519_bib201","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.puhe.2022.01.017","article-title":"Living with endemic COVID-19","volume":"205","author":"Lee","year":"2022","journal-title":"Public Health"},{"issue":"5","key":"10.1016\/j.rmed.2025.108519_bib202","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/S2213-2600(20)30161-2","article-title":"Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations","volume":"8","author":"Phua","year":"2020","journal-title":"Lancet Respir. Med."},{"issue":"3","key":"10.1016\/j.rmed.2025.108519_bib203","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/SHK.0000000000000633","article-title":"Pulmonary angiotensin-converting enzyme 2 (ACE2) and inflammatory lung disease","volume":"46","author":"Jia","year":"2016","journal-title":"Shock"},{"issue":"7","key":"10.1016\/j.rmed.2025.108519_bib204","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1001\/jamainternmed.2020.0994","article-title":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China","volume":"180","author":"Wu","year":"2020","journal-title":"JAMA Intern. Med."},{"issue":"1","key":"10.1016\/j.rmed.2025.108519_bib205","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/s12931-021-01791-z","article-title":"Global incidence and prevalence of idiopathic pulmonary fibrosis","volume":"22","author":"Maher","year":"2021","journal-title":"Respir. Res."},{"issue":"1","key":"10.1016\/j.rmed.2025.108519_bib206","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1186\/s12890-025-03836-1","article-title":"Incidence and prevalence of idiopathic pulmonary fibrosis: a systematic literature review and meta-analysis","volume":"25","author":"Golchin","year":"2025","journal-title":"BMC Pulm. Med."},{"issue":"3","key":"10.1016\/j.rmed.2025.108519_bib207","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.ijtb.2020.11.003","article-title":"Post COVID-19 pulmonary fibrosis. Is it a real threat?","volume":"68","author":"Rai","year":"2021","journal-title":"Indian J. Tubercul."},{"issue":"13","key":"10.1016\/j.rmed.2025.108519_bib208","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1080\/10408398.2020.1775546","article-title":"Obesity as a risk factor for COVID-19: an overview","volume":"61","author":"Alberca","year":"2021","journal-title":"Crit. Rev. Food Sci. Nutr."},{"issue":"7","key":"10.1016\/j.rmed.2025.108519_bib209","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1093\/gerona\/glp040","article-title":"Use of senescence-accelerated mouse model in bleomycin-induced lung injury suggests that bone marrow\u2013derived cells can alter the outcome of lung injury in aged mice","volume":"64","author":"Xu","year":"2009","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"10.1016\/j.rmed.2025.108519_bib210","doi-asserted-by":"crossref","first-page":"20","DOI":"10.18332\/tid\/119324","article-title":"COVID-19 and smoking: a systematic review of the evidence","volume":"18","author":"Vardavas","year":"2020","journal-title":"Tob. Induc. Dis."},{"key":"10.1016\/j.rmed.2025.108519_bib211","doi-asserted-by":"crossref","DOI":"10.1164\/ajrccm.2025.211.Abstracts.A2624","article-title":"Post COVID-19 lung fibrosis and the role of inflammatory markers: a prospective observational study [abstract]","volume":"211","author":"Agrawal","year":"2025","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2025.108519_bib212","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.823600","article-title":"Characteristics and prognostic factors of pulmonary fibrosis after COVID-19 pneumonia","volume":"8","author":"Cocconcelli","year":"2022","journal-title":"Front. Med."},{"key":"10.1016\/j.rmed.2025.108519_bib213","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.805535","article-title":"The interaction between pulmonary fibrosis and COVID-19 and the application of related antifibrotic drugs","volume":"12","author":"Shen","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.rmed.2025.108519_bib214","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1218059","article-title":"Molecular mechanisms of COVID-19-induced pulmonary fibrosis and epithelial-mesenchymal transition","volume":"14","author":"Pi","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.rmed.2025.108519_bib215","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117905","article-title":"Protective role of ACE2 and its downregulation in SARS-CoV-2 infection leading to macrophage Activation syndrome: therapeutic implications","volume":"256","author":"Banu","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.rmed.2025.108519_bib216","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1218059","article-title":"Molecular mechanisms of COVID-19-induced pulmonary fibrosis and epithelial-mesenchymal transition","volume":"14","author":"Pi","year":"2023","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.rmed.2025.108519_bib217","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.03132-2021","article-title":"Genetic overlap between idiopathic pulmonary fibrosis and COVID-19","volume":"60","author":"Allen","year":"2022","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2025.108519_bib218","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-98505-y","article-title":"Cytokine profiles dynamics in COVID-19 patients: a longitudinal analysis of disease severity and outcomes","volume":"15","author":"Ghaffarpour","year":"2025","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.rmed.2025.108519_bib219","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.pccm.2022.12.002","article-title":"Pulmonary fibrosis: a short- or long-term sequelae of severe COVID-19?","volume":"1","author":"Zheng","year":"2023","journal-title":"Chin. Med. J. Pulm. Crit. Care Med."},{"issue":"2","key":"10.1016\/j.rmed.2025.108519_bib220","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01808-2020","article-title":"Rapid onset honeycombing fibrosis in spontaneously breathing patient with COVID-19","volume":"56","author":"Combet","year":"2020","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2025.108519_bib221","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104759","article-title":"A potential role for integrins in host cell entry by SARS-CoV-2","volume":"177","author":"Sigrist","year":"2020","journal-title":"Antivir. Res."},{"issue":"6","key":"10.1016\/j.rmed.2025.108519_bib222","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0253347","article-title":"SARS-CoV-2 uses major endothelial integrin \u03b1v\u03b23 to cause vascular dysregulation in-vitro during COVID-19","volume":"16","author":"Nader","year":"2021","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.rmed.2025.108519_bib223","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1074\/jbc.M708033200","article-title":"Severe acute respiratory syndrome-associated coronavirus nucleocapsid protein interacts with Smad3 and modulates transforming growth factor-beta signaling","volume":"283","author":"Zhao","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.rmed.2025.108519_bib224","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1038\/s41467-025-57267-x","article-title":"Respiratory long COVID in aged hamsters features impaired lung function post-exercise with bronchiolization and fibrosis","volume":"16","author":"Heydemann","year":"2025","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.rmed.2025.108519_bib225","doi-asserted-by":"crossref","first-page":"3850","DOI":"10.3390\/ijms26083850","article-title":"Challenges and opportunities for Post-COVID pulmonary disease: a focused review of immunomodulation","volume":"26","author":"Verbeeck Mendez","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.rmed.2025.108519_bib226","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.748931","article-title":"Common molecular pathways between Post-COVID19 syndrome and lung fibrosis: a scoping review","volume":"13","author":"Bergantini","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"180","key":"10.1016\/j.rmed.2025.108519_bib227","doi-asserted-by":"crossref","first-page":"22","DOI":"10.24976\/Discov.Med.202436180.3","article-title":"Idiopathic pulmonary fibrosis: where do we stand and how far to go?","volume":"36","author":"Singh","year":"2024","journal-title":"Discov. Med."},{"issue":"1","key":"10.1016\/j.rmed.2025.108519_bib228","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1186\/s40001-025-02640-1","article-title":"Tetrathiomolybdate alleviates bleomycin-induced pulmonary fibrosis by reducing copper concentration and suppressing EMT","volume":"30","author":"Wang","year":"2025","journal-title":"Eur. J. Med. Res."},{"key":"10.1016\/j.rmed.2025.108519_bib229","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2024.1450038","article-title":"Notch signaling regulates pulmonary fibrosis","volume":"12","author":"Zhang","year":"2024","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.rmed.2025.108519_bib230","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1444964","article-title":"Macrophage polarization and its impact on idiopathic pulmonary fibrosis","volume":"15","author":"Ge","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.rmed.2025.108519_bib231","doi-asserted-by":"crossref","first-page":"41","DOI":"10.70470\/SHIFAA\/2023\/005","article-title":"CRISPR-Cas9 mediated gene correction of CFTR mutations in cystic fibrosis: evaluating efficacy, safety, and long-term outcomes in patient-derived lung organoids","volume":"2023","author":"D\u00f6larslan","year":"2023","journal-title":"SHIFAA"},{"issue":"5","key":"10.1016\/j.rmed.2025.108519_bib232","doi-asserted-by":"crossref","first-page":"333","DOI":"10.2174\/1566523220666201012145731","article-title":"CRISPR\/Cas9 genome editing tool: a promising tool for therapeutic applications on respiratory diseases","volume":"20","author":"Shaikh","year":"2020","journal-title":"Curr. Gene Ther."},{"issue":"3","key":"10.1016\/j.rmed.2025.108519_bib233","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1513\/AnnalsATS.202305-402OC","article-title":"The impact of occupational exposures on the risk of idiopathic pulmonary fibrosis: a systematic review and meta-analysis","volume":"21","author":"Gandhi","year":"2024","journal-title":"Ann. Am. Thorac. Soc."},{"issue":"22","key":"10.1016\/j.rmed.2025.108519_bib234","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242216481","article-title":"Environmental causes of idiopathic pulmonary fibrosis","volume":"24","author":"Gandhi","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.rmed.2025.108519_bib235","article-title":"Arsenic exposure and lung fibrotic changes \u2013 evidence from a longitudinal cohort study and experimental models","volume":"14","author":"Wang","year":"2023","journal-title":"Front. Immunol."},{"issue":"14","key":"10.1016\/j.rmed.2025.108519_bib236","doi-asserted-by":"crossref","first-page":"7237","DOI":"10.3390\/ijerph18147237","article-title":"Quantitation of silica contents in lung explants of transplanted patients: artificial stone-induced silicosis vs. idiopathic pulmonary fibrosis","volume":"18","author":"Fireman","year":"2021","journal-title":"Int. J. Environ. Res. Publ. Health"},{"key":"10.1016\/j.rmed.2025.108519_bib237","article-title":"Natural products for anti-fibrotic therapy in idiopathic pulmonary fibrosis: marine and terrestrial insights","volume":"16","author":"Ma","year":"2025","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.rmed.2025.108519_bib238","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trsl.2020.07.009","article-title":"MicroRNA and protein-coding gene expression analysis in idiopathic pulmonary fibrosis yields novel biomarker signatures associated to survival","volume":"228","author":"Casanova","year":"2021","journal-title":"Transl. Res."},{"issue":"4","key":"10.1016\/j.rmed.2025.108519_bib239","doi-asserted-by":"crossref","first-page":"173","DOI":"10.4103\/atm.atm_7_23","article-title":"Post-COVID-19 pulmonary fibrosis: an ongoing concern","volume":"18","author":"Alrajhi","year":"2023","journal-title":"Ann. Thorac. Med."},{"key":"10.1016\/j.rmed.2025.108519_bib240","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.748931","article-title":"Common molecular pathways between post-COVID-19 syndrome and lung fibrosis: a scoping review","volume":"13","author":"Bergantini","year":"2022","journal-title":"Front. Pharmacol."}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611125005827?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611125005827?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:29:44Z","timestamp":1773880184000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611125005827"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":239,"alternative-id":["S0954611125005827"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2025.108519","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emerging molecular targets and natural therapeutics for idiopathic pulmonary fibrosis: Insights into mechanisms, risks, and COVID-19 links","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2025.108519","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108519"}}